1748
J. Zhang et al.
Letter
Synlett
(3) For selected examples, see: (a) Ma, S.; Lu, X. J. Org. Chem. 1991,
56, 5120. (b) Zhu, G.; Lu, X. J. Org. Chem. 1995, 60, 1087. (c) Ji, J.;
Wang, Z.; Lu, X. Organometallics 1996, 15, 2821. (d) Wang, Z.;
Lu, X.; Lei, A.; Zhang, Z. J. Org. Chem. 1998, 63, 3806. (e) Zhang,
Q.; Lu, X. J. Am. Chem. Soc. 2000, 122, 7604. (f) Zhao, L.; Lu, X.
Org. Lett. 2002, 4, 3903. (g) Zhao, B.; Lu, X. Org. Lett. 2006, 8,
5987. (h) Liu, G.; Lu, X. J. Am. Chem. Soc. 2006, 128, 16504.
(i) Dai, H.; Lu, X. Org. Lett. 2007, 9, 3077. (j) Yu, X.; Lu, X. Org.
Lett. 2009, 11, 4366. (k) Lin, S.; Lu, X. Org. Lett. 2010, 12, 2536.
(l) Han, X.; Lu, X. Org. Lett. 2010, 12, 3336. (m) Shen, K.; Han, X.;
Lu, X. Org. Lett. 2013, 15, 1732. (n) Xia, G.; Han, X.; Lu, X. Org.
Lett. 2014, 16, 2058.
Cantor, G. H.; Mathias, N.; Moench, P.; Denton, R.; Macci, R.;
Schartman, R.; Whiterock, V.; Davis, C.; Macor, J. E.; Dubowchik,
G. M. Bioorg. Med. Chem. Lett. 2013, 23, 3157.
(9) For reviews, see: (a) Jones, G. In Comprehensive Heterocyclic
Chemistry II; Vol. 5; Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V.,
Eds.; Pergamon: New York, 1996, 167. (b) Balasubramanian, M.;
Keay, J. G. In Comprehensive Heterocyclic Chemistry II; Vol. 5;
Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V., Eds.; Pergamon:
Oxford, 1996, 245. (c) Larsen, R. D. In Science of Synthesis; Vol.
15; Georg Thieme Verlag: Stuttgart, 2005, 551.
(10) For recent examples, see: (a) Wu, J.; Xiang, S.; Zeng, J.; Leow, M.;
Liu, X.-W. Org. Lett. 2015, 17, 222. (b) Wang, Z.; Xue, L.; He, Y.;
Weng, L.; Fang, L. J. Org. Chem. 2014, 79, 9628. (c) Mai, W.-P.;
Sun, G.-C.; Wang, J.-T.; Song, G.; Mao, P.; Yang, L.-R.; Yuan, J.-W.;
Xiao, Y.-M.; Qu, L.-B. J. Org. Chem. 2014, 79, 8094. (d) Dong, Y.;
Liu, B.; Chen, P.; Liu, Q.; Wang, M. Angew. Chem. Int. Ed. 2014,
53, 3442. (e) Manikandan, R.; Jeganmohan, M. Org. Lett. 2014,
16, 3568. (f) Ferguson, J.; Zeng, F.; Alwis, N.; Alper, H. Org. Lett.
2013, 15, 1998. (g) Xie, P.; Wang, Z.-Q.; Deng, G.-B.; Song, R.-J.;
Xia, J.-D.; Hu, M.; Li, J.-H. Adv. Synth. Catal. 2013, 355, 2257.
(h) Inamoto, K.; Kawasaki, J.; Hiroya, K.; Kondo, Y.; Doi, T. Chem.
Commun. 2012, 48, 4332.
(11) For examples of N-transacylation reactions of amides with car-
boxylic acids, see: (a) Michman, M.; Patai, S.; Shenfeld, I. J.
Chem. Soc. C 1967, 1337. (b) Michman, M.; Meidar, D. J. Chem.
Soc., Perkin Trans. 2 1972, 300.
(12) Synthesis of 2-Quinolinones; General Procedure: Pd(OAc)2 (5
mol%), 4,4′-(MeO)2bpy (10 mol%), and MS (20% w/w) were sus-
pended in AcOH–DCE (1:2, 2 mL) and stirred at room tempera-
ture for 5 min under N2. Substrate 1 (0.2 mmol) was added and
the mixture was stirred at 80 °C. The progress of the reaction
was monitored by TLC. Upon completion of the reaction, the
mixture was purified by silica gel column chromatography to
afford the corresponding product.
(4) Zhao, L.; Lu, X. Angew. Chem. Int. Ed. 2002, 41, 4343.
(5) Zhang, J.; Han, X. Adv. Synth. Catal. 2014, 356, 2465.
(6) (a) Chung, H.-S.; Woo, W.-S. J. Nat. Prod. 2001, 64, 1579. (b) Ito,
C.; Itoigawa, M.; Furukawa, A.; Hirano, T.; Murata, T.; Kaneda,
N.; Hisada, Y.; Okuda, K.; Furukawa, H. J. Nat. Prod. 2004, 67,
1800. (c) Grabley, S.; Thiericke, R. Drug Discovery from Nature;
Springer-Verlag: Berlin, 1999, 124. (d) He, J.; Lion, U.; Sattler, I.;
Gollmick, F.-A.; Grabley, S.; Cai, J.; Meiner, M.; Schaumann, K.;
Dechert, U.; Krohn, M. J. Nat. Prod. 2005, 68, 1397.
(7) For recent reviews on biological studies of 2-quinolinones, see:
(a) Poulie, C. B. M.; Bunch, L. ChemMedChem 2013, 8, 5. (b) Heeb,
S.; Fletcher, M. P.; Chhabra, S. R.; Diggle, S. P.; Williams, P.;
Cámara, M. FEMS Microbiol. Rev. 2011, 35, 247.
(8) For recent selected examples on medicinal activities of 2-quino-
linones, see: (a) Wolkenberg, S. E.; Zhao, Z.; Thut, C.; Maxwell, J.
W.; McDonald, T. P.; Kinose, F.; Reilly, M.; Lindsley, C. W.;
Hartman, G. D. J. Med. Chem. 2011, 54, 2351. (b) Sabbah, D. A.;
Simms, N. A.; Wang, W.; Dong, Y.; Ezell, E. L.; Brattain, M. G.;
Vennerstrom, J. L.; Zhong, H. A. Bioorg. Med. Chem. 2012, 20,
7175. (c) Kumar, N.; Raj, V. P.; Jayshree, B. S.; Kar, S. S.;
Anandam, A.; Thomas, S.; Jain, P.; Rai, A.; Rao, C. M. Chem. Biol.
Drug Des. 2012, 80, 291. (d) Beattie, D.; Beer, D.; Bradley, M. E.;
Bruce, I.; Charlton, S. J.; Cuenoud, B. M.; Fairhurst, R. A.; Farr, D.;
Fozard, J. R.; Janus, D.; Rosethorne, E. M.; Sandham, D. A.; Sykes,
D. A.; Trifilieff, A.; Turner, K. L.; Wissler, E. Bioorg. Med. Chem.
Lett. 2012, 22, 6280. (e) Doléans-Jordheim, A.; Veron, J. B.;
Fendrich, O.; Bergeron, E.; Montagut-Romans, A.; Wong, Y. S.;
Furdui, B.; Freney, J.; Dumontet, C.; Boumendjel, A. ChemMed-
Chem 2013, 8, 652. (f) Chaturvedula, P. V.; Mercer, S. E.; Pin, S.
S.; Thalody, G.; Xu, C.; Conway, C. M.; Keavy, D.; Signor, L.;
3-Acetylquinolin-2(1H)-one (2a)
Yield: 31 mg (82%); white solid; 1H NMR (400 MHz, DMSO-d6):
δ = 12.09 (s, 1 H), 8.43 (s, 1 H), 7.85 (dd, J = 1.0, 7.8 Hz, 1 H),
7.62–7.58 (m, 1 H), 7.33 (d, J = 8.4 Hz, 1 H), 7.23–7.19 (m, 1 H),
2.61 (s, 3 H); 13C NMR (100 MHz, DMSO-d6): δ = 197.8, 160.9,
143.5, 140.9, 133.3, 130.6, 129.8, 122.8, 118.5, 115.4, 31.1.
(13) Menashe, N.; Shvo, Y. J. Org. Chem. 1993, 58, 7434.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2015, 26, 1744–1748